The hormone that balances oestrogen, supports fertility, promotes restful sleep and keeps your mood steady throughout your cycle.
Progesterone is a steroid hormone produced primarily by the corpus luteum — the temporary glandular structure that forms in the ovary after ovulation. During pregnancy, the placenta takes over production. It is the essential counterpart to oestrogen: where oestrogen builds and stimulates, progesterone calms, protects and stabilises. Its influence extends far beyond reproduction — progesterone shapes mood, sleep architecture, thyroid function and the delicate oestrogen-progesterone balance that governs nearly every aspect of women's hormonal health.
| Form | Role | Too Low / Side Effects | Too High / Concerns |
|---|---|---|---|
| Endogenous Progesterone | Prepares uterine lining, supports early pregnancy, promotes sleep and calm via allopregnanolone conversion | Irregular/heavy periods, PMS, anxiety, insomnia, early miscarriage | Drowsiness, bloating, breast tenderness (usually at pharmacological doses) |
| Micronised Progesterone (Utrogestan) | Chemically identical to body's own progesterone; best sleep and mood profile of all progestogens | — | Drowsiness (often beneficial taken at night) |
| Synthetic Progestins (e.g. MPA, norethisterone) | Provides endometrial protection but does not share progesterone's GABA-calming or sleep-supportive effects | — | Depression, low libido, acne, clot risk (varies by type) |
Low progesterone is more common than most women realise — and the causes span from lifestyle factors to hormonal transitions. Identifying the underlying reason determines the most appropriate response.
Progesterone is typically the first hormone to decline in perimenopause — often years before oestrogen falls. Anovulatory cycles increase, reducing progesterone production and causing oestrogen dominance, heavier periods and mood changes in the 40s.
'Pregnenolone steal' — chronic cortisol demand diverts the shared precursor (pregnenolone) away from progesterone synthesis. Results in low luteal phase progesterone with normal E2, causing PMS, anxiety and poor sleep.
No ovulation means no corpus luteum and therefore no progesterone. PCOS, hypothalamic amenorrhoea, extreme exercise and undereating all suppress ovulation, creating oestrogen-dominant, progesterone-deficient cycles.
A short or inadequate luteal phase — insufficient corpus luteum function produces progesterone that peaks too low or drops too early. Associated with PMS, spotting before periods, and difficulty maintaining early pregnancy.
Much of progesterone's effect on mood, anxiety and sleep is mediated not by progesterone itself, but by its conversion to allopregnanolone (ALLO) — a powerful neurosteroid that modulates the brain's GABA system. Understanding this pathway explains why some women feel dramatically better on micronised progesterone, and why synthetic progestins provide no equivalent benefit.
GABA-A receptor modulation
Allopregnanolone is a positive allosteric modulator of GABA-A receptors — the same target as benzodiazepines. It produces anxiolytic, sedative and anticonvulsant effects.
Sleep architecture
Oral micronised progesterone significantly increases slow-wave (deep) sleep — a unique and clinically valuable effect not shared by synthetic progestins.
PMDD connection
Women with PMDD have abnormal sensitivity to normal ALLO fluctuations — their GABA system reacts paradoxically, causing anxiety rather than calm.
Postnatal depression
The dramatic drop in progesterone (and therefore ALLO) after childbirth is a key driver of postnatal mood changes and depression.
Brexanolone (Zulresso)
The first FDA-approved treatment for postnatal depression is synthetic allopregnanolone — directly confirming ALLO's role in mood disorders.
Not replicated by progestins
Synthetic progestins do not convert to allopregnanolone and provide none of these neurological benefits — and may worsen mood in sensitive women.
7 min read
8 min read
8 min read
8 min read
7 min read
8 min read
9 min read
6 min read
6 min read
9 min read
6 min read
8 min read
Progesterone is often called the body’s calming hormone — and for good reason. While oestrogen tends to stimulate and build, progesterone balances, calms and protects. The interplay between these two hormones is central to women’s health across every life stage, and when progesterone becomes insufficient, the effects can be wide-ranging and significantly impact quality of life.
Produced by the corpus luteum after ovulation and by the placenta during pregnancy, progesterone’s primary reproductive role is to prepare the uterine lining for implantation and maintain early pregnancy. This is why low progesterone is a key factor in recurrent early pregnancy loss — without sufficient progesterone, the uterine lining cannot sustain a growing embryo.
Beyond reproduction, progesterone’s neurological effects are profound. Its metabolite allopregnanolone acts as a positive modulator of GABA-A receptors in the brain — the same receptors targeted by anti-anxiety medications. This is why adequate progesterone is associated with feelings of calm, emotional stability and good sleep quality, while progesterone deficiency often presents as anxiety, irritability and insomnia.
During perimenopause, progesterone is typically the first hormone to decline — often years before oestrogen levels fall significantly. This early drop in progesterone can trigger many of the mood and sleep disturbances women notice in their 40s, long before typical menopausal symptoms begin. Recognising this hormonal shift is key to seeking appropriate support early.
For South African women considering hormone replacement therapy, the choice between synthetic progestins and micronised progesterone matters. Research, including the large French E3N cohort study, suggests that combined HRT using micronised progesterone carries a lower breast cancer risk than formulations using synthetic progestins. Discussing this distinction with your gynaecologist or menopause specialist is an important step in making an informed decision about HRT.
If you suspect low progesterone — whether due to PMS, irregular cycles, fertility challenges or perimenopausal symptoms — a day 21 blood test (measuring serum progesterone seven days before your expected period) is the standard starting point. HealthLab’s professional directory can help you find a qualified specialist to guide you through testing and treatment options.